Augusto Medina Saldana
Hematology & Oncology · Bayamon, PRNPI 1598758377
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 286 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,326 and has fallen 99.3% since, to $17 in 2025. That places this record below the midpoint for hematology & oncology clinicians in PR, where the typical reported total is $10,882.
Across 286 payments — averaging $20.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$992
- E.r. Squibb & Sons, L.L.C.$809
- AstraZeneca$587
- Eli Lilly Export S.A. Puerto Rico Branch$493
- Amgen$465
- Novartis$361
- plus $2K from 21 others
What the payments were for
- Food & beverage$5,63395%
- Education$3245%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 43 | $992 |
| E.r. Squibb & Sons, L.L.C. | 49 | $809 |
| AstraZeneca | 29 | $587 |
| Eli Lilly Export S.A. Puerto Rico Branch | 17 | $493 |
| Amgen | 15 | $465 |
| Novartis | 21 | $361 |
| Merck | 19 | $343 |
| Bristol Myers Squibb | 14 | $313 |
| Genentech USA, Inc. | 17 | $305 |
| PBG Puerto Rico LLC | 13 | $240 |
| AbbVie | 10 | $197 |
| GSK | 4 | $167 |
| Sanofi | 7 | $128 |
| Lilly USA, LLC | 3 | $116 |
| Pfizer | 6 | $89 |
| Eisai Inc. | 3 | $56 |
| Clovis Oncology, Inc. | 3 | $53 |
| Taiho Oncology, Inc. | 2 | $41 |
| Puma Biotechnology, Inc. | 2 | $34 |
| Incyte Corporation | 2 | $33 |
| Bayer | 1 | $25 |
| Verity Pharmaceuticals Inc. | 1 | $25 |
| Rigel Pharmaceuticals, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Pfizer Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEJULA$124
How this compares
$5,957 in reported general payments places this provider in the 35th percentile of 138 hematology & oncology providers in Puerto Rico.
Other hematology & oncology in Bayamon
- Yelitza RuizBayamon$28K
- Kenel Fernandez BarbosaBayamon$24K
- Robert HunterBayamon$23K
- Juan Vazquez MedinaBayamon$20K
- Myrna Andino CamachoBayamon$20K
- Elias Sobrino NajulBayamon$17K
- Carlos ChiesaBayamon$17K
- Alexis Cruz ChaconSan Juan$450K
- Jose Lozada CostasSan Juan$260K
- Cristian Rodriguez ArochoSan Juan$227K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.